VCP
AGN

Vernier Capital Partners’s Allergan plc AGN Stock Holding History

Vernier Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-95,150
Closed -$21.9M – 23
2016
Q3 		$21.9M Buy
95,150
+19,550
+26% +$4.78M 5.65% 5
2016
Q2 		$17.5M Buy
75,600
+33,588
+80% +$7.74M 4.91% 9
2016
Q1 		$11.3M Buy
+42,012
New +$12M 4.88% 9

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vernier Capital Partners's AGN Position: Q4 2016 in Review

Vernier Capital Partners sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 95,150 shares — an estimated $21.9M sold.

Vernier Capital Partners first reported a position in AGN in Q1 2016 and held it in 3 quarters. The position peaked at $21.9M in Q3 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Vernier Capital Partners reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Vernier Capital Partners sold 95,150 Allergan plc shares in Q4 2016, an estimated $21.9M.
  • Vernier Capital Partners first reported a position in Allergan plc in Q1 2016 and held it in 3 quarters.
  • Vernier Capital Partners's Allergan plc position peaked at $21.9M in Q3 2016.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Vernier Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.